Maximizing Immunotherapy Approaches in Hard-to-Treat CancersMarch 25th 2015
Cancer proliferates when a rogue, transformed cell wins a sophisticated hide-and-seek game against the immune system. Immunotherapy activates the patientâ€™s immune system to recognize and fight the tumor cells.
Tumor Antigens and Their Role in Immune Response in MelanomaMarch 24th 2015
Melanoma is the most deadly skin cancer. According to data collected between 2004 and 2010, only 16% of Americans with metastatic melanoma, including people of all ages and races, and both genders, survive for 5 years or more after diagnosis.